
Keywords: Non-coding RNA; Biomarkers; Oncomirs; Tumor suppressor; Androgen receptor; Castrate-resistant prostate cancer; AR; androgen receptor; ARHI; Ras homolog member I; BCR; biochemical recurrence; BPH; benign prostatic hyperplasia; BTG-2; B-cell translocation g